The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period
Open Access
- 1 January 2024
- journal article
- research article
- Published by Taylor & Francis in Pharmacogenomics and Personalized Medicine
- Vol. ume 17, 41-49
Abstract
Introduction: The polymorphism of the gene coding mu-opioid receptor (OPRM1) is one of the factors contributing to the variability in the response to opioid analgesics in children. The goal of this study is to investigate its role in association with postoperative acute pain in children of various ages. Methods: This prospective study analyzed 110 pediatric patients, after plastic or orthopedic surgery, who were genotyped and randomly assigned to receive fentanyl or alfentanil. Postoperative pain was rated using Numerical Rating Scale (0– 10). All the patients were genotyped forOPRM1 118A>G (rs1799971) gene polymorphism. Results: School children under the age of 11 with the OPRM1 AA genotype were shown to have a higher BMI (p< 0.05). Children over the age of 12 carrying G allele OPRM1, had increased postoperative pain sensitivity and intensity (3.28± 1.95 vs 4.91± 2.17; p< 0.05), as compared to AA allele carriers. Discussion: OPRM1 118A>G polymorphism may explain the variation in the perception of postoperative pain in children over the age of 12 and may be a useful predictor for adjusting the dose of analgesics, but the dose is relative to the patient’s needs regardless of his genetic characteristics. In younger children, carriers of polymorphic OPRM1 118G allele may be protected from obesity, due to diminished MOP expression.Keywords
This publication has 39 references indexed in Scilit:
- First Evidence of a Polygenic Susceptibility to Pain in a Pediatric CohortAnesthesia & Analgesia, 2013
- Characteristics of highly impaired children with severe chronic pain: a 5-year retrospective study on 2249 pediatric pain patientsBMC Pediatrics, 2012
- Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patientsPain, 2011
- Blood sample volumes in child health research: review of safe limitsBulletin of the World Health Organization, 2010
- Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in μ-opioid receptor-deficient miceEuropean Journal of Pharmacology, 2008
- The μ-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriersPharmacogenetics and Genomics, 2006
- Human Opioid Receptor A118G Polymorphism Affects Intravenous Patient-controlled Analgesia Morphine Consumption after Total Abdominal HysterectomyAnesthesiology, 2006
- Association of μ‐opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplastyActa Anaesthesiologica Scandinavica, 2006
- The development of nociceptive circuitsNature Reviews Neuroscience, 2005
- The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant diseaseActa Anaesthesiologica Scandinavica, 2004